Nasdaq - Delayed Quote USD

PGIM Jennison Health Sciences Fund (PHLAX)

38.18 +0.10 (+0.26%)
At close: 8:01 PM EDT

Top 10 Holdings (50.50% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 11.61%
MRK
Merck & Co., Inc. 7.52%
ABBV
AbbVie Inc. 6.61%
UNH
UnitedHealth Group Incorporated 4.35%
VRTX
Vertex Pharmaceuticals Incorporated 4.21%
APLS
Apellis Pharmaceuticals, Inc. 3.67%
CI
The Cigna Group 3.45%
BDX
Becton, Dickinson and Company 3.15%
BSX
Boston Scientific Corporation 3.01%
NVO
Novo Nordisk A/S 2.92%

Sector Weightings

SectorPHLAX
Healthcare   99.43%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 3.44%
Stocks 96.56%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average PHLAX Category Average
Price/Earnings 0.02 24.55
Price/Book 0.16 5.28
Price/Sales 0.3 2.06
Price/Cashflow 0.05 17.54
Median Market Cap 60,406.47 34,862.81
3 Year Earnings Growth -3.6 32.48

Bond Holdings

Performance & Risk

YTD Return 5.56%
5y Average Return 11.36%
Rank in Category (ytd) 6
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.69
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family PGIM Investments
Net Assets 1.84B
YTD Return 13.08%
Yield 0.00%
Morningstar Rating
Inception Date Jun 30, 1999

Fund Summary

The fund seeks investments whose prices will increase over time. It normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector, such as pharmaceutical companies, biotechnology companies, medical device manufacturers, healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets, revenues or profits from operations in the healthcare sector.

Related Tickers